Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
CTSD positive + ER positive
Cancer:
Breast Cancer
Drug:
tamoxifen
(
Estrogen receptor antagonist
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
AACR 2022
Title:
5495 - PHI-501, a potent and novel inhibitor of NRAS mutated acute myeloid leukemia
Published date:
03/09/2022
Excerpt:
Cathepsin D positive tumors with ER positive staining who were treated with tamoxifen were associated with lower BCSS...
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login